• Opinion
• [Reporter’s View] Please wait for policies to take effect
• by Lee, Tak-Sun Jun 1, 2023 05:39am

• Company
• Keytruda is expected to enter the domestic market
• by Eo, Yun-Ho Jun 1, 2023 05:38am

• Company
• Lyumjev can be prescribed at general hospitals
• by Eo, Yun-Ho May 31, 2023 05:37am

• Policy
• Vemlidy IMDs compete with lower price
• by Lee, Tak-Sun May 31, 2023 05:37am

• Company
• Samsung Bioepis, Soliris biosimilar approved in Europe
• by Chon, Seung-Hyun May 31, 2023 05:36am

• Company
• Verzenio prescribing guideline recommendations
• by Eo, Yun-Ho May 31, 2023 05:36am

• Company
• 2 K-biosimilars are approved in the US and Europe per year
• by Chon, Seung-Hyun May 31, 2023 05:36am

• Company
• Sales of Keytruda rose 117%
• by Chon, Seung-Hyun May 30, 2023 06:59pm

• Product
• Prof Seong-Hoon Kim's research team reveals the mechanism
• by Jung, Heung-Jun May 30, 2023 05:33am

• Policy
• Lowest price of dapagliflozin set at 30% of original price
• by Lee, Tak-Sun May 30, 2023 05:33am